Roche Holding AG (RHHBY)
35.44
+0.15
(+0.42%)
USD |
OTCM |
Nov 22, 16:00
Roche Enterprise Value: 258.79B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 258.79B |
| November 21, 2024 | 257.83B |
| November 20, 2024 | 256.81B |
| November 19, 2024 | 258.60B |
| November 18, 2024 | 260.26B |
| November 15, 2024 | 261.34B |
| November 14, 2024 | 263.25B |
| November 13, 2024 | 268.86B |
| November 12, 2024 | 270.97B |
| November 11, 2024 | 272.69B |
| November 08, 2024 | 272.62B |
| November 07, 2024 | 276.19B |
| November 06, 2024 | 273.64B |
| November 05, 2024 | 280.91B |
| November 04, 2024 | 284.22B |
| November 01, 2024 | 283.14B |
| October 31, 2024 | 280.27B |
| October 30, 2024 | 284.41B |
| October 29, 2024 | 286.90B |
| October 28, 2024 | 289.83B |
| October 25, 2024 | 291.49B |
| October 24, 2024 | 290.98B |
| October 23, 2024 | 289.13B |
| October 22, 2024 | 282.69B |
| October 21, 2024 | 284.03B |
| Date | Value |
|---|---|
| October 18, 2024 | 285.05B |
| October 17, 2024 | 282.06B |
| October 16, 2024 | 281.99B |
| October 15, 2024 | 283.78B |
| October 14, 2024 | 282.57B |
| October 11, 2024 | 282.63B |
| October 10, 2024 | 280.65B |
| October 09, 2024 | 277.72B |
| October 08, 2024 | 276.83B |
| October 07, 2024 | 275.04B |
| October 04, 2024 | 273.64B |
| October 03, 2024 | 276.89B |
| October 02, 2024 | 281.93B |
| October 01, 2024 | 283.01B |
| September 30, 2024 | 287.54B |
| September 27, 2024 | 288.75B |
| September 26, 2024 | 288.88B |
| September 25, 2024 | 286.90B |
| September 24, 2024 | 287.54B |
| September 23, 2024 | 284.67B |
| September 20, 2024 | 284.35B |
| September 19, 2024 | 284.41B |
| September 18, 2024 | 285.37B |
| September 17, 2024 | 283.59B |
| September 16, 2024 | 282.82B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
213.58B
Minimum
May 02 2024
368.95B
Maximum
Dec 28 2021
289.63B
Average
288.99B
Median
Enterprise Value Benchmarks
| Novo Nordisk AS | 464.12B |
| Pfizer Inc | 202.30B |
| Amgen Inc | 209.71B |
| Eli Lilly and Co | 737.78B |
| Merck & Co Inc | 274.49B |
Enterprise Value Related Metrics
| Earnings Yield | 5.21% |
| Operating Earnings Yield | 7.20% |
| Normalized Earnings Yield | 5.403 |